[ad_1]
In the maneuver, 400 million euros have already been allocated for the vaccination campaign in Italy, “secret” warehouses are being sought for storage at very low temperatures, the organizational machine is put into operation. Since last Monday one of the multinationals in the race, Pfizer (in collaboration with BioNTech), announced that the anti-Covid vaccine is proving to be 90% effective, the attention of Italy and the rest of the world has focused on this. topic. Professor Ugur Sahin, co-founder of BioNTech, therefore one of Pfizer’s vaccine developers, warned in an interview with the BBC: “Human-to-human transmission will be reduced with such an effective vaccine, perhaps not by 90 percent. , but at least 50. And this should lead to a drastic reduction in the spread of the pandemic. During the summer of 2021 there will be a concrete impact of the new vaccine, and by next winter we will return to normal. ”
READ ALSO -> Vaccine Pfizer, creator Ugur Sahin: “We will return to normal from winter 2022”
The race has begun: guest of “Half an hour more”, Professor Guido Silvestri (virologist at Emory University in Atlanta) explained that before Christmas (therefore in a month) “will begin the vaccination of health workers in United States”. . But this should be the week that will also reserve accelerations for other vaccines: the first is Moderna’s, also in the United States, and like Pfizer’s, it is based on messenger RNA; an announcement on the effectiveness is expected these days. Cristina Cassetti, an Italian virologist for 17 years at the Niaid National Institute of Infectious Diseases directed by Anthony Fauci, explains to Ansa: “There are many possibilities that by the end of the year we will have not one, but two vaccines against Covid-19, approved with emergency authorization by the Food and Drug Administration (FDA) “. Fauci explained: “The Pfizer result validates the mRna platform.
Moderna is a candidate for mRna, there are similar results ». At the same time, the green light from Ema (the European authority) is expected between the end of November and the beginning of December for the vaccine developed by the Jenner Institute of Oxford in collaboration with Irbm of Pomezia, and produced and marketed by the British giant. Sweden’s AstraZeneca, which will announce the conclusion of phase 3 of the trial in one or two weeks. If for Pfizer Italia it will resort to the contract signed by the European Union that must reserve a first batch of 27 million doses for our country (1.7 already in January), for AstraZeneca there is a preferential channel, given that an agreement for months was signed for 70 million doses. The Serum Institute, AstraZeneca’s partner for India, announced that as early as December it plans to start delivering 100 million global doses. In summary: between December and January, although in a limited number of people, the historic vaccination operation will begin in various parts of the world (not to mention what has already begun in China with the administration of health personnel and the Army). Well, how is the plan going in Italy? Commissioner Domenico Arcuri has two channels to prepare (but other vaccines could be added in the coming weeks). Pfizer’s requires the complex organization of the cold chain, because the vaccine must always be kept at a temperature below -70 degrees. Pfizer has studied cartons containing 1,200 doses, but regional “central” warehouses will still be needed to then deliver the containers to hospitals.
In five days, if the vial is subsequently left in a traditional refrigerator, the administration must be carried out, otherwise the vaccine becomes ineffective. That is why you have to find warehouses with special cold rooms but also means of transport. In the case of AstraZeneca, however, a temperature between minus 4 and minus 8 degrees Celsius is sufficient. But for both vaccines, there are many safety concerns: we are talking about something that will change our lives, while every day we see that between 500 and 600 people die from Covid. The military will participate and vaccine storage locations will be kept as confidential as possible.
Last Updated: November 16, 00:47
© REPRODUCTION RESERVED
[ad_2]
